Master in 암의생명과학과

암의생명과학과, or Cancer Biomedical Science, focuses on the biological mechanisms of cancer, from tumor formation and progression to the development of diagnostic tools and treatments. Students in this field typically study molecular oncology, cancer genetics, cell biology, immunology, and pharmacology, along with laboratory techniques used in cancer research such as cell culture, gene expression analysis, and animal models of disease. Coursework often connects basic biomedical science with translational research, preparing students to work on the path between laboratory discovery and clinical application. This master's program is offered at the National Cancer Center Graduate School of Cancer Science and Policy in Goyang, South Korea, taught in English, running two years with admission in March and September. Because the program is housed within a dedicated cancer research institution, students have the opportunity to study alongside researchers and clinicians working directly on cancer science and treatment development. Graduates of cancer biomedical science programs typically pursue careers as researchers in academic or government cancer centers, roles in pharmaceutical and biotechnology companies developing cancer therapies, or further doctoral study in oncology-related fields. The discipline also supports careers in clinical trial research, drug discovery, and diagnostic technology development. Given the global demand for improved cancer detection and treatment, training in cancer biomedical science provides graduates with specialized knowledge applicable to both research and industry settings. Students who complete this program gain a foundation in both the scientific and applied dimensions of oncology, positioning them for work at the intersection of laboratory research and cancer care.